Market Tracker

03/24 5:16pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Mar 24
 +0.1084 / +0.26%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / - Paid Partner Content
Should You Buy Pharma ETFs Now?
Mar 15 / - Paid Partner Content


1 month-2.80% 3 years+0.01%
3 months+2.57% 5 years+11.51%
1 year+4.78% Since inception+11.78%
Data through 03/25/2017

Quote Details

Previous close$40.93
Open day’s range40.87 – 41.19
Net asset value (NAV)41.04 (03/24/2017)
Daily volume95,998
Average volume (3 months)260,450
Data as of 3:59pm ET, 03/24/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+11.51%+16.84%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.651.11
Net assets$473.0M$3.0B
Average market cap$9.2B$30.5B
Average P/E22.422.3
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MDCO Medicines Co5.61%
JAZZ Jazz Pharmaceuticals PLC5.41%
AGN Allergan5.31%
LLY Eli Lilly and Co5.09%
MYL Mylan NV4.78%
JNJ Johnson & Johnson4.54%
HZNP Horizon Pharma PLC4.52%
PFE Pfizer4.49%
MRK Merck4.49%
ZTS Zoetis Inc4.29%